Coronary stents, angioplasty, and bypass are treated as heart surgery on almost every final expense application — and heart surgery runs on a calendar. The published ladders cluster around the same marks: inside 12 months, a modified or graded plan (or no offer); one to two years, a middle tier with full day-one coverage; past two years, the best tiers. American Home Life’s Patriot Series is the clean example — Modified, then Standard, then Preferred after 24 months — while NewBridge needs five years for its top class.
Two carriers break the pattern. Transamerica’s 2023 Immediate Solution chart files stents, bypass, and angioplasty under heart disease — a day-one tier with no lookback as a single condition — and its 2026 FE Express guide keeps them on a day-one class even inside the first year. Corebridge’s SimpliNow Legacy guide lists “some stable coronary conditions treated with stents or by-pass surgery” among scenarios eligible for its level plan. The caveat: Transamerica routes two Standard-rated conditions together to graded, and both carriers say the rest of the application still counts.
Besides the date, three things move your tier. Anything pending — a recommended cath or bypass not yet done is a hard stop at several carriers. What you take — American Amicable rates Plavix by first-fill date, and Mutual of Omaha lists Plavix and warfarin as “additional information” medications, not declines. And what else is on the chart — NewBridge lists diabetes combined with a heart disorder as not eligible. Beneath it all, guaranteed-issue whole life asks no health questions: Mutual of Omaha’s runs to age 85, Corebridge’s and Americo’s to 80, with a graded period for natural-cause death in the first two years (three at Americo) and full accidental coverage from day one.